Standout Papers
- Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids (1999)
- Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy (2002)
- Vascular Inflammation and Repair (2011)
- Uric acid and cardiovascular disease: A clinical review (2020)
- Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial (2024)
Immediate Impact
8 by Nobel laureates 4 from Science/Nature 58 standout
Citing Papers
Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Works of Koichi Node being referenced
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
2024 Standout
The Effect of Semaglutide on Mortality and COVID-19–Related Deaths
2024
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Koichi Node | 4770 | 2812 | 2797 | 3658 | 542 | 15.0k | |
| Dominik N. Müller | 4471 | 3560 | 2079 | 4451 | 322 | 16.3k | |
| Mitsuhiro Yokoyama | 5007 | 1865 | 2935 | 3999 | 374 | 15.5k | |
| Akira Kitabatake | 7166 | 1837 | 3477 | 2732 | 375 | 14.2k | |
| Masatoshi Fujishima | 3183 | 1925 | 2538 | 2489 | 638 | 14.3k | |
| Takao Saruta | 5820 | 4779 | 2169 | 3743 | 526 | 15.2k | |
| David D. Gutterman | 5608 | 1331 | 2263 | 3069 | 244 | 14.8k | |
| Claudio Napoli | 4421 | 1653 | 3539 | 6121 | 443 | 19.9k | |
| Dao Wen Wang | 6189 | 2210 | 1600 | 9429 | 600 | 20.8k | |
| Edwin K. Jackson | 3014 | 2414 | 1315 | 5706 | 491 | 19.0k | |
| Hiromi Rakugi | 6592 | 3522 | 2768 | 4676 | 601 | 20.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...